SPEX — Spexis AG Cashflow Statement
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
Annual cashflow statement for Spexis AG, fiscal year end - December 31st, CHF millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -64.7 | -44.9 | -11.9 | -18.6 | -19.6 |
| Depreciation | |||||
| Non-Cash Items | 2.05 | 3.62 | 10.1 | 5.54 | 12.9 |
| Discontinued Operations | |||||
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 4.3 | -3.13 | 0.619 | -0.363 | 0.327 |
| Change in Accounts Receivable | |||||
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -56 | -42.4 | -1.13 | -12 | -5.48 |
| Capital Expenditures | -0.503 | -0.048 | — | -0.017 | — |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 1.88 | 0 | 3.43 | 0 | 0 |
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Cash from Investing Activities | 1.38 | -0.048 | 3.43 | -0.017 | 0 |
| Financing Cash Flow Items | -0.635 | 2.02 | 1.88 | -0.197 | -0.406 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -1.48 | 1.09 | 11.8 | -1.33 | 4.35 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -56.4 | -43.1 | 14.1 | -12.6 | -1.29 |